Study links gut microbiome and aggressive prostate cancer

by Cleveland ClinicCredit: CC0 Public DomainCleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, su

Updated on: April 20,2024

Study links gut microbiome and aggressive prostate cancer

by Cleveland ClinicCredit: CC0 Public DomainCleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, su

Updated on:April 20,2024

Engineered white blood cells can eliminate cancer, shows study

by Melissa Pappas,University of PennsylvaniaMacrophages killing cancer cell. Credit: Susan ArnoldBy silencing the molecular pathway that prevents macrophages from attacking our own cells, Univer

Updated on: January 16,2024

Engineered white blood cells can eliminate cancer, shows study

by Melissa Pappas,University of PennsylvaniaMacrophages killing cancer cell. Credit: Susan ArnoldBy silencing the molecular pathway that prevents macrophages from attacking our own cells, Univer

Updated on:January 16,2024

Living alone doesn't have to mean being lonely, says study

by Sebastian Hollstein, Friedrich-Schiller-Universität JenaLiving alone does not necessarily mean isolation and loneliness, according to a recent study by the University of Jena. Credit: Jens Meyer/Un

Updated on: May 21,2024

Living alone doesn't have to mean being lonely, says study

by Sebastian Hollstein, Friedrich-Schiller-Universität JenaLiving alone does not necessarily mean isolation and loneliness, according to a recent study by the University of Jena. Credit: Jens Meyer/Un

Updated on:May 21,2024

Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer

byUniversity of Texas M. D. Anderson Cancer CenterOncoprint of targeted somatic gene variants of tumors in patients with anaplastic thyroid cancer (atc) enrolled in cohorts 1 to 3. Credit:

Updated on: November 11,2024

Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer

byUniversity of Texas M. D. Anderson Cancer CenterOncoprint of targeted somatic gene variants of tumors in patients with anaplastic thyroid cancer (atc) enrolled in cohorts 1 to 3. Credit:

Updated on:November 11,2024

Study shows how to make (and destroy) a metastatic cancer cell

by CU Anschutz Medical CampusColorado study shows that inhibiting the lysosomal stage of autophagy (and not necessarily the action of the autophagosome) may kill metastatic cancer cells. Credit:

Updated on: May 31,2024

Study shows how to make (and destroy) a metastatic cancer cell

by CU Anschutz Medical CampusColorado study shows that inhibiting the lysosomal stage of autophagy (and not necessarily the action of the autophagosome) may kill metastatic cancer cells. Credit:

Updated on:May 31,2024

First-in-class targeted microRNA therapy slows cancer tumor growth

by Purdue UniversityA new therapy targets cancer cells with a modified strand of micro-RNA that naturally blocks cell division. Credit: Second Bay Studios/Purdue UniversityA new cancer therapy de

Updated on: February 18,2024

First-in-class targeted microRNA therapy slows cancer tumor growth

by Purdue UniversityA new therapy targets cancer cells with a modified strand of micro-RNA that naturally blocks cell division. Credit: Second Bay Studios/Purdue UniversityA new cancer therapy de

Updated on:February 18,2024

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on: December 01,2024

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on:December 01,2024

Study finds volume of liver resection during gallbladder surgery doesn't significantly affect overall survival

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainGallbladder cancer is most common in people who have gallstones or have had gallstones in the past. While uncommon, most ga

Updated on: January 23,2024

Study finds volume of liver resection during gallbladder surgery doesn't significantly affect overall survival

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainGallbladder cancer is most common in people who have gallstones or have had gallstones in the past. While uncommon, most ga

Updated on:January 23,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on: February 20,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on:February 20,2024

'Double life' of key immune protein reveals new strategies for treating cancer and autoimmune diseases

by NYU Langone HealthCredit: CC0 Public DomainInsights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengt

Updated on: March 20,2024

'Double life' of key immune protein reveals new strategies for treating cancer and autoimmune diseases

by NYU Langone HealthCredit: CC0 Public DomainInsights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengt

Updated on:March 20,2024

New cancer immunotherapy approach turns human cells into tiny anti-tumor drug factories

by University of California - San DiegoUC San Diego School of Medicine researchers developed a method to use B cells to manufacture and secrete microRNA-containing vesicles and showed they can in

Updated on: March 12,2024

New cancer immunotherapy approach turns human cells into tiny anti-tumor drug factories

by University of California - San DiegoUC San Diego School of Medicine researchers developed a method to use B cells to manufacture and secrete microRNA-containing vesicles and showed they can in

Updated on:March 12,2024

Gene signature to tailor chemotherapy shows promise for improving breast cancer survival

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainUsing a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to

Updated on: November 08,2024

Gene signature to tailor chemotherapy shows promise for improving breast cancer survival

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainUsing a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to

Updated on:November 08,2024